Related Articles
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor‑positive/progesterone receptor‑negative breast cancer
Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta‑analysis
Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer
Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: A retrospective study
Neoadjuvant treatments for resectable rectal cancer: A network meta‑analysis